Kopran Ltd. (KOPRAN) Share Price Near 52-Week High as Stock Trades at Rs 273.25
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Kopran Ltd. Share Price is trading at Rs 273.25, up 1.73% today, and remains close to its 52-week high while the company carries a market capitalisation of Rs 1,258.32 crore. The latest Univest figures place Kopran Ltd. (KOPRAN) in the spotlight because the share price is holding near its yearly high zone as the market update continues at 18 September 2026 at 12:18 PM IST. Kopran Ltd. Share Price Today is relevant not because a new price record has been stated, but because the current level sits near the 52-week peak and gives investors a fresh read on valuation, sector positioning and stock performance. The latest Univest data confirms the price event, while it does not establish a company-specific catalyst.
Kopran Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 273.25 |
| Previous Close | Rs 268.6 |
| Today's Move | +Rs 4.65 (+1.73%) |
| Open | Rs 267.55 |
| High | Rs 276.5 |
| Low | Rs 261 |
| Turnover | Rs 1.97 crore |
| Market Capitalisation | Rs 1,258.32 crore |
Kopran Ltd. (KOPRAN) traded at Rs 273.25 versus the previous close of Rs 268.6, a rise of 1.73%. The stock opened at Rs 267.55, reached a high of Rs 276.5 and touched a low of Rs 261.
Kopran Ltd. Share Price Today opened at Rs 267.55, traded between Rs 261 and Rs 276.5, and was last seen at Rs 273.25. The move of Rs 4.65 over the previous close of Rs 268.6 translates into a 1.73% rise, with turnover at Rs 1.97 crore. That keeps Kopran Ltd. Stock News focused on a near 52-week high event rather than a fresh directional thesis. In practical terms, the price is trading above the previous close and within the upper part of the day’s range, while the market has not provided a company-specific reason for the move. For readers tracking Kopran Ltd. Share Price Live, the main point is that the stock is now sitting close to its yearly high area and remains active in today’s market update. Kopran Ltd. Share Price therefore deserves attention from investors who are screening 52 Week High Stocks and Stocks in News, even though the verified numbers alone do not explain the trigger. The next section turns to the latest Univest analysis of valuation and financial context.
Kopran Ltd. (KOPRAN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,258.32 crore |
| P/E Ratio | 51.95x |
| P/B Ratio | 2.42x |
| ROE | 4.92% |
| ROCE | 6.65% |
| EPS | Rs 5.17 |
| Book Value Per Share | Rs 110.92 |
| Dividend Yield | 1.12% |
Kopran Ltd. (KOPRAN) fundamental metrics show P/E 51.95x, P/B 2.42x, ROE 4.92%, ROCE 6.65%. These figures provide context only and are not a buy or sell signal.
Kopran Ltd. has a market capitalisation of Rs 1258.32 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 51.95x, P/B at 2.42x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.92% and ROCE of 6.65%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.17, book value per share of Rs 110.92, dividend yield of 1.12%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 51.95x |
| Benchmark Median P/E | 28.19x |
| Benchmark Average P/E | 37.49x |
| Benchmark P/E Range | 0x to 417.17x |
| Company P/B Ratio | 2.42x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 4.92% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 6.65% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 1,258.32 crore |
| Benchmark Median Market Cap | Rs 733.35 crore |
Kopran Ltd. (KOPRAN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Kopran Ltd. (KOPRAN) has a P/E ratio of 51.95x, which is above the benchmark median of 28.19x, a difference of +84.29%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Kopran Ltd. (KOPRAN) has a ROE of 4.92%, which is below the benchmark median of 11.78%, a difference of -58.23%. Kopran Ltd. (KOPRAN) has a ROCE of 6.65%, which is below the benchmark median of 13.65%, a difference of -51.28%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sigachi Industries Ltd. | SIGACHI | 1,192.97 | 44.2 | 2.12 | 14.49 | 16.42 |
| Lincoln Pharmaceuticals Ltd. | LINCOLN | 1,183.36 | 12.48 | 1.52 | 13.02 | 17.55 |
| Fermenta Biotech Ltd. | FERMENTA | 1,379.87 | 22.64 | 3.32 | 18.36 | 21.99 |
| Amrutanjan Health Care Ltd. | AMRUTANJAN | 1,415.46 | 26.26 | 3.78 | 16.62 | 22.46 |
| Themis Medicare Ltd. | THEMISMED | 1,108.89 | 36.45 | 3.67 | 7.65 | 10.37 |
Kopran Ltd. (KOPRAN) has a P/E ratio of 51.95x compared with the displayed peer median of 26.26x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.92% compares with a peer median of 14.49% across the companies shown in the table. ROCE stood at 6.65% versus the displayed peer median of 17.55%, providing a capital-efficiency comparison. Kopran Ltd. (KOPRAN) has a market capitalisation of Rs 1,258.32 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Kopran Ltd.
- Kopran Ltd. Share Price is trading at Rs 273.25, which is near its 52-week high and above the previous close of Rs 268.6.
- The day’s range stretched from Rs 261 to Rs 276.5, showing where Kopran Ltd. Share Price Today was traded during the market update.
- Market capitalisation stands at Rs 1,258.32 crore, which keeps Kopran Ltd. Market Cap in the listed healthcare comparison set.
- Valuation is marked by a P/E of 51.95, a P/B of 2.42, EPS of Rs 5.17 and book value of Rs 110.92.
- ROE of 4.92 and ROCE of 6.65 sit below the same-industry benchmark figures shown for Pharmaceuticals & Drugs.
About Kopran Ltd.
Kopran Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company profile used in this market note is built around its listed identity as Kopran Ltd. (KOPRAN), with financial and market data carrying the main explanatory weight. For readers searching Kopran Ltd. Company News or Kopran Ltd. Latest News, the essential context is that the stock is being tracked near a 52-week high while market cap, valuation, EPS, book value and dividend yield remain central to the current discussion. Univest continues to present Kopran Ltd. Share Price in a structured way so that investors can follow the share price, ratios and sector position in one place.
Frequently Asked Questions
Why is Kopran Ltd. Share Price in focus today?
Ans. Kopran Ltd. Share Price is in focus because it is trading at Rs 273.25, which is near its 52-week high. The stock is also up 1.73% from the previous close of Rs 268.6.
What is Kopran Ltd. Share Price Today?
Ans. Kopran Ltd. Share Price Today is Rs 273.25. The stock moved within a range of Rs 261 to Rs 276.5 during the market update and carried turnover of Rs 1.97 crore.
Is Kopran Ltd. near its 52-week high?
Ans. Yes, Kopran Ltd. Share Price is trading close to its 52-week high zone. The latest move places the stock near its yearly peak area rather than at a fresh record level.
What does Kopran Ltd. Market Cap show?
Ans. Kopran Ltd. Market Cap stands at Rs 1,258.32 crore. That places the company above the same-industry market-cap median of Rs 733.35 crore, while still far below the industry average.
How does Kopran Ltd. compare on valuation?
Ans. Kopran Ltd. Share Price is paired with a P/E of 51.95 and a P/B of 2.42. The P/E is above the same-industry median, while the P/B is below both the median and average.
What do EPS and book value say about Kopran Ltd.?
Ans. Kopran Ltd. reports EPS of Rs 5.17 and book value of Rs 110.92. EPS reflects earnings per share, while book value shows accounting net worth per share behind Kopran Ltd. Share Price.
How does Kopran Ltd. look against healthcare peers?
Ans. Among listed peers, Kopran Ltd. Share Price carries a higher P/E than several names in the sample, while ROE and ROCE remain below most peer figures. Market cap is broadly in the same band.
What should investors monitor next in Kopran Ltd. Share Price?
Ans. Investors can monitor whether Kopran Ltd. Share Price stays near its 52-week high zone and how valuation, revenue trends, EPS and sector comparisons evolve in the next market update.
Track Kopran Ltd. Share Price on Univest
Use Kopran Ltd. (KOPRAN) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Kopran Ltd. Share Price on Univest for live share price updates, market cap, 52-week levels, valuation ratios, company financials, peer comparison and broader market insights. Univest brings Kopran Ltd. Share Price Today together with Kopran Ltd. Stock News, Kopran Ltd. Fundamental Analysis and stock-specific data in one place for faster monitoring.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
